SQM (ADR) (SQM)
Transforms Chilean brine and caliche plus Australian hard rock into lithium, iodine, and specialty chemicals.
Something off on this page? Send us feedback.
Produces lithium and derivatives, iodine, specialty plant nutrients, potassium products, and industrial chemicals from Chilean caliche and brine plus Australian hard rock. Integrated processing reaches multiple chemical markets, while products from Salar de Atacama generate roughly half of revenue and now operate through the state-partnered Nova Andino Litio venture.
Produces lithium carbonate and hydroxide, iodine and derivatives, specialty plant nutrients, potassium products, and industrial chemicals. Northern Chilean caliche supplies nitrates and iodine, Salar de Atacama brine supplies lithium and potassium, and Western Australian spodumene supports a second lithium chain linked to Kwinana refining.
Integrated extraction and conversion turn three mineral systems into multiple chemical products. Production remains concentrated in Chile, while Australia adds hard-rock lithium and China adds conversion capacity. The portfolio spans several end markets rather than relying on lithium alone.
Products originating in Salar de Atacama generate roughly half of revenue. Those operations sit inside Nova Andino Litio under long-dated Corfo contracts, with SQM initially retaining operating control before Codelco assumes it. Environmental obligations require staged reductions in brine and industrial-water extraction, and the Australian refinery remains in ramp-up.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 27, 2026 | Citigroup | Upgrade | ||
| Aug 26, 2026 | Citigroup | Upgrade | ||
| Aug 24, 2026 | Scotiabank | Reiterate | Rating: —Target: $93 | Target: $104 |
| Aug 20, 2026 | Deutsche Bank | Target | Target: $98 | Target: $94 |
| Jul 28, 2026 | Scotiabank | Reiterate | Rating: —Target: $105 | Target: $93 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $4.33B · Total debt $5.29B · Total assets $16.58B · Shareholders' equity $6.29B
- Revenue
- $2.47B
- Operating income
- $1.21B
- Net income
- $660.1M
HistoryDividendAnnual yield
| Institutions | ≈ 13.30% | 37.98M ADS | |
|---|---|---|---|
| 327 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Other | ≈ 86.70% | 247.66M ADS | |
| remainder | |||
285.64M ADS as of Sep 19, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Dec 2022 annual report; nothing newer is on file here.
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
This company has 2 share classes; every stake here is a share of the whole company.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Baillie Gifford & CoInstitution | 1.66% | 4.73M B ADS | as of Jun 30, 2026 |
Van Eck Associates CorpInstitution | 0.93% | 2.66M B ADS | as of Jun 30, 2026 |
BlackRock, Inc.Institution | 0.83% | 2.37M B ADS | as of Jun 30, 2026 |
Earnest Partners LLCInstitution | 0.74% | 2.10M B ADS | as of Jun 30, 2026 |
Grantham, Mayo, van Otterloo & Co. LLCInstitution | 0.56% | 1.61M B ADS | as of Jun 30, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- Albemarle
Major lithium-chemicals rival across carbonate and hydroxide
- ICL
Broad overlap in potash and specialty crop nutrition
- Rio Tinto (ADR)
Scaled lithium platform built around Arcadium and new projects
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| SQM (ADR) | $70.56 | +1.47% | $19.86B | 14.3 | 9.0 | 2.9 | +136.7% |
| Albemarle | $113.80 | +0.77% | $13.32B | — | 11.6 | 2.3 | +31.1% |
| ICL | $5.36 | +0.28% | $6.89B | 22.2 | 12.2 | 0.9 | +16.5% |
| Rio Tinto (ADR) | $96.80 | −0.25% | $157.69B | 13.2 | — | 2.6 | +57.4% |
| Median | 17.7 | 11.9 | 2.3 | +31.1% |